Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Valeant Phramaceuticals is defending its drug discount program for two expensive heart drugs against reports that hospitals are not seeing any savings. The Canadian drugmaker said the program will cover more than 90 percent of the costs for U.S. hospitals,…
The Food and Drug Administration approved Bayer's hormonal contraceptive device Kyleena, reported Reuters.
Medeon Biodesign recently earned Food and Drug Administration approval for AbClose, a port site closure device.
Here are the six latest medical devices or drugs approved by the U.S. Food and Drug Administration.
Six Massachusetts hospitals are participating in a $3.6 million equity funding round to support Blue.Point, an Andover, Mass.-based healthcare startup company, according to the Boston Business Journal.
The Food and Drug Administration recently approved Yosprala, a pill that combines aspirin with the gastrointestinal drug omeprazole to prevent stomach ulcers in patients who take aspirin daily, according to Reuters.
Approval may be around the corner for Sarepta Therapeutics' Duchenne muscular dystrophy drug Eteplirsen since its biggest critic, Ronald Farkas, MD, PhD, left his role at the Food and Drug Administration, according to CNBC.
Dublin-based Medtronic received Food and Drug Administration approval for an expanded indication of its drug-coated balloon.
An advisory panel for the Food and Drug Administration concluded Wednesday a serious warning on the label of Pfizer's anti-smoking drug Chantix should be removed, according to Reuters,
Dublin, Ireland-based Allergan will purchase Fort Washington, Pa.-based clinical-stage biotechnology company Vitae Pharmaceuticals for $639 million, twice its market value, according to The Wall Street Journal.